MD Anderson experience with off-study regorafenib in patients with advanced colorectal cancer.
Diogo Bugano Diniz Gomes
No relevant relationships to disclose
Hesham M. Hassabo
No relevant relationships to disclose
Salwan S. Al Mutar
No relevant relationships to disclose
Ibrahim Halil Sahin
No relevant relationships to disclose
Jane Rogers
No relevant relationships to disclose
D. Van Nguyen
No relevant relationships to disclose
Ryan M. Bolonesi
No relevant relationships to disclose
Tunghi May Pini
No relevant relationships to disclose
Arvind Dasari
No relevant relationships to disclose
Scott Kopetz
No relevant relationships to disclose
Michael J. Overman
No relevant relationships to disclose
Cathy Eng
No relevant relationships to disclose
Bryan K. Kee
No relevant relationships to disclose
Manal Hassan
No relevant relationships to disclose
Chris R. Garrett
No relevant relationships to disclose